Company retains an influential clinician for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Charles H. Adler, MD, PhD, has accepted to serve on neuropacs’ Board of Clinical Advisors. “Dr. Adler brings much clinical expertise and insight…

Read more about Neuropacs Enrolls Dr. Charles H. Adler on its Board of Clinical Advisors

Company secures a seasoned entrepreneur for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Dr. Jackson Streeter has accepted to serve on neuropacs’ Board of Directors. Dr. Streeter comes to neuropacs as the current Director of UF-Innovate/Ventures…

Read more about Neuropacs Retains Dr. Jackson Streeter as a Member of its Board of Directors

Company retains an influential clinician for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that David K. Simon, MD, PhD, has accepted to serve on neuropacs’ Board of Clinical Advisors. “Dr. Simon brings cutting-edge clinical expertise to neuropacs”…

Read more about Neuropacs Enrolls Dr. David K. Simon on its Board of Clinical Advisors

Company brings a world-acclaimed clinician and researcher for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Dr. Ostrem has accepted to serve on neuropacs’ Board of Clinical Advisors. Dr. Jill Ostrem is a movement disorders neurologist and…

Read more about Neuropacs Welcomes Dr. Jill Ostrem as the latest Member of its Board of Clinical Advisors

Company retains entrepreneur and philanthropist to contribute to the launch of neuropacs’ innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Mr. Rick Staab has accepted to serve on neuropacs’ Board of Directors. Mr. Rick Staab is the former President and CEO of…

Read more about Neuropacs Retains Mr. Rick Staab as a Member of their Board of Directors

Company retains a visionary collaborator for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Reza Forghani, MD, PhD has accepted to serve on neuropacs’ Board of Clinical Advisor, effective immediately. Dr. Forghani is a member of the…

Read more about Neuropacs Enrolls Dr. Reza Forghani to its Board of Clinical Advisors

Company retains an influential clinical collaborator for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Adolfo Ramirez-Zamora, MD, has accepted to serve on neuropacs’ Board of Clinical Advisors, effective immediately. Dr. Ramirez-Zamora is a Professor of Neurology,…

Read more about Neuropacs Enrolls Dr. Ramirez-Zamora on its Board of Clinical Advisors

GAINESVILLE, FL – neuropacsTM, a leading innovator in medical diagnostics, is excited to announce the acquisition of an exclusive option agreement for a groundbreaking diagnostic technology for Alzheimer’s disease developed at the University of Florida. This innovative technology, spearheaded by neuropacsTM‘s Co-Founder and Chief Scientific Officer, David Vaillancourt, has the potential to revolutionize early detection…

Read more about Revolutionary Alzheimer’s Diagnostic Technology Option Agreement Secured by neuropacs in Collaboration with UF

GAINESVILLE, FL – Michael Okun, MD has accepted to serve on neuropacs’ Board of Clinical Advisors and will not be compensated, to maintain clinical independence and ensure no actual or perceived conflicts of interest.

Read more about Dr. Michael Okun Joins Neuropacs’ Board of Clinical Advisors

Company grows management team in preparation for the launch of its AI-driven algorithm for the diagnosis of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Mr. Dwight L. Hulse MBA, MPA, CPA/CITP, CGMA, CA(BZ) will serve as their fractional Chief Financial Officer, effective immediately. Mr. Hulse is…

Read more about Neuropacs appoints Dwight L. Hulse as their fractional CFO